Analyst Recommendations

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for XP on April 22, 2024 06:18PM ET. XP was trading at $21.11 at issue of the analyst recommendation.The overall analyst consensus...

April 23, 2024   XP 1.79%

Wells Fargo analyst issues EQUAL-WEIGHT recommendation for TSLA on April 22, 2024 06:32PM ET. The previous analyst recommendation was Underweight.TSLA was trading at $142.05 at issue of the...

April 23, 2024   TSLA 3.74%

Wells Fargo analyst issues OVERWEIGHT recommendation for DIS on April 23, 2024 05:07AM ET. The previous analyst recommendation was Overweight.DIS was trading at $111.99 at issue of the...

April 23, 2024   DIS 0.70%

Wells Fargo analyst issues EQUAL-WEIGHT recommendation for VZ on April 23, 2024 05:08AM ET. The previous analyst recommendation was Equal-Weight.VZ was trading at $38.6 at issue of the...

April 23, 2024   VZ 2.00%

Piper Sandler analyst issues OVERWEIGHT recommendation for MSFT on April 22, 2024 04:41AM ET. The previous analyst recommendation was Overweight.MSFT was trading at $399.12 at issue of the...

April 22, 2024   MSFT -1.51%

Morgan Stanley analyst issues OVERWEIGHT recommendation for AAPL on April 22, 2024 01:33AM ET. The previous analyst recommendation was Overweight.AAPL was trading at $165 at issue of the...

April 22, 2024   AAPL -0.38%

Jefferies analyst issues BUY recommendation for CRM on April 21, 2024 05:30PM ET. The previous analyst recommendation was Buy.CRM was trading at $270.37 at issue of the analyst...

April 22, 2024   CRM 1.47%

Barclays analyst issues EQUAL-WEIGHT recommendation for MT on April 19, 2024 03:01PM ET. The previous analyst recommendation was Equal-Weight.MT was trading at $25.31 at issue of the analyst...

April 19, 2024   MT -0.50%

Goldman Sachs analyst issues BUY recommendation for TSM on April 19, 2024 12:31PM ET. The previous analyst recommendation was Buy.TSM was trading at $127.75 at issue of the...

April 19, 2024   TSM -0.92%

National Bank analyst issues OUTPERFORM recommendation for CVE on April 19, 2024 01:02PM ET. The previous analyst recommendation was Outperform.CVE was trading at $21 at issue of the...

April 19, 2024   CVE 1.01%